These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7626627

  • 1. Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering.
    Chatterton JE, Schlapfer P, Bütler E, Gutierrez MM, Puppione DL, Pullinger CR, Kane JP, Curtiss LK, Schumaker VN.
    Biochemistry; 1995 Jul 25; 34(29):9571-80. PubMed ID: 7626627
    [Abstract] [Full Text] [Related]

  • 2. Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects.
    Arnold KS, Balestra ME, Krauss RM, Curtiss LK, Young SG, Innerarity TL.
    J Lipid Res; 1994 Aug 25; 35(8):1469-76. PubMed ID: 7989871
    [Abstract] [Full Text] [Related]

  • 3. Studying low-density lipoprotein-monoclonal antibody complexes using dynamic laser light scattering and analytical ultracentrifugation.
    Gutierrez MM, Tsai SW, Phillips ML, Curtiss LK, Milne RW, Schumaker VN.
    Biochemistry; 1999 Jan 26; 38(4):1284-92. PubMed ID: 9930989
    [Abstract] [Full Text] [Related]

  • 4. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach.
    Pietzsch J, Wiedemann B, Julius U, Nitzsche S, Gehrisch S, Bergmann S, Leonhardt W, Jaross W, Hanefeld M.
    J Lipid Res; 1996 Oct 26; 37(10):2074-87. PubMed ID: 8906585
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
    Durovic S, März W, Frank S, Scharnagl H, Baumstark MW, Zechner R, Kostner GM.
    J Biol Chem; 1994 Dec 02; 269(48):30320-5. PubMed ID: 7982944
    [Abstract] [Full Text] [Related]

  • 9. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.
    Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP.
    J Clin Invest; 1995 Mar 02; 95(3):1225-34. PubMed ID: 7883971
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.
    Young SG, Bertics SJ, Curtiss LK, Casal DC, Witztum JL.
    Proc Natl Acad Sci U S A; 1986 Feb 02; 83(4):1101-5. PubMed ID: 2419898
    [Abstract] [Full Text] [Related]

  • 11. Heritable allele-specific differences in amounts of apoB and low-density lipoproteins in plasma.
    Gavish D, Brinton EA, Breslow JL.
    Science; 1989 Apr 07; 244(4900):72-6. PubMed ID: 2565046
    [Abstract] [Full Text] [Related]

  • 12. The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
    Borén J, Ekström U, Agren B, Nilsson-Ehle P, Innerarity TL.
    J Biol Chem; 2001 Mar 23; 276(12):9214-8. PubMed ID: 11115503
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An ApaLI restriction site polymorphism is associated with the MB19 polymorphism in apolipoprotein B.
    Young SG, Hubl ST.
    J Lipid Res; 1989 Mar 23; 30(3):443-9. PubMed ID: 2470848
    [Abstract] [Full Text] [Related]

  • 15. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies.
    Pietzsch J, Lattke P, Julius U.
    Arterioscler Thromb Vasc Biol; 2000 Oct 23; 20(10):E63-7. PubMed ID: 11031225
    [Abstract] [Full Text] [Related]

  • 16. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins.
    Ludwig EH, Hopkins PN, Allen A, Wu LL, Williams RR, Anderson JL, Ward RH, Lalouel JM, Innerarity TL.
    J Lipid Res; 1997 Jul 23; 38(7):1361-73. PubMed ID: 9254062
    [Abstract] [Full Text] [Related]

  • 17. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
    Goldberg IJ, Wagner WD, Pang L, Paka L, Curtiss LK, DeLozier JA, Shelness GS, Young CS, Pillarisetti S.
    J Biol Chem; 1998 Dec 25; 273(52):35355-61. PubMed ID: 9857078
    [Abstract] [Full Text] [Related]

  • 18. Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100.
    Raungaard B, Heath F, Hansen PS, Brorholt-Petersen JU, Jensen HK, Faergeman O.
    Clin Chem; 2000 Feb 25; 46(2):224-33. PubMed ID: 10657378
    [Abstract] [Full Text] [Related]

  • 19. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
    Schewe CK, Schuster H, Hailer S, Wolfram G, Keller C, Zöllner N.
    Eur J Clin Invest; 1994 Jan 25; 24(1):36-41. PubMed ID: 8187806
    [Abstract] [Full Text] [Related]

  • 20. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.
    Weisgraber KH, Innerarity TL, Newhouse YM, Young SG, Arnold KS, Krauss RM, Vega GL, Grundy SM, Mahley RW.
    Proc Natl Acad Sci U S A; 1988 Dec 25; 85(24):9758-62. PubMed ID: 3200853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.